secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enovix Corp (ENVX)
CIK:        0001828318
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001828318-23-000202
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enovix Q3 revenue $0.2M; cash $371.3M; narrows FY2023 cash use guidance to $110M
--------------------------------------------------------------------------------

- Q3 revenue $0.2M from U.S. Army cells; GAAP cost of revenue $16.8M; GAAP op. expenses $33.8M.
- Cash, equivalents, and short-term investments $371.3M; Q3 operating cash use $28.2M; capex $17.3M.
- FY2023 operational cash use forecast lowered to $110M (from $120M); capex to $65M (from $70M).
- Completed FAT for one Gen2 production zone; expects all four zones FAT by Jan 2024; first samples by Apr 2024.
- Acquired Routejade for electrode coating; Fab1 restructuring reduces annualized cash burn ~$22M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828318/000182831823000202/0001828318-23-000202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828318/000182831823000202/envx-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001828318-23-000202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer